Biological Samples
Conditions
Keywords
drone transport, biological samples, unmanned aerial system, UAS
Brief summary
The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Transport by air will be between the CHAM, the Abbeville Hospital and the CHU Amiens-Picardie by flying as much as possible over the waterways via the Somme. With a flight speed of around 100km/h at an altitude between 80 and 120 m, drones will be able to connect sites in less than an hour by transporting packages between 2 and 3 kg. Powered by propellers connected to rechargeable batteries, these drones do not emit CO2. This type of transport has not been validated in France by measuring the analytical impact of transport constraints for medical biology, and has never been evaluated according to the criteria of ISO 15189 standard allowing the certification of medical biology laboratories. Validation steps of this transportation method are therefore necessary on pathological samples prior to routine use. The aim of the project is to verify the absence of analytical impact of the transport of pathological biological samples by drone under defined flight conditions, according to the ISO15189 norm.
Interventions
OTHERdrone transport
additional transport of samples at room temperature by drone (departure from the CHU Amiens-Picardie, 1 hour flight in the CHU Amiens-Picardie air perimeter, return to the CHU Amiens-Picardie)
Sponsors
Centre Hospitalier Universitaire, Amiens
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients admitted to the Amiens-Picardie University Hospital and having benefited from medical biology examinations including the parameters of interest * according to the usual management modalities and without additional sampling * at the time of the test period
Exclusion criteria
* Refusal to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| variation of HIL concentration between both groups | one day |
| variation of ASAT concentration between both groups | one day |
| variation of ALAT concentration between both groups | one day |
| variation of BNP concentration between both groups | one day |
| variation of LDH concentration between both groups | one day |
| variation of Glucose concentration between both groups | one day |
| variation of Troponin concentration between both groups | one day |
| variation of Potassium concentration between both groups | one day |
Countries
France
Outcome results
None listed